⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002094941

Verduyn-van Weegen Felice Isabel

Reports to the SEC for 2 companies · ANTWERPEN

Transactions

6

Companies

2

Filings

2

CIK

0002094941

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-17	EVMNEvommune, Inc.A Award	Director, 10% Owner	AAward	+359K sh	$27.88	+$10M	5,288,313
2025-11-07	EVMNEvommune, Inc.C Conversion	Director, 10% Owner	CConversion	+3.37M sh	—	—	3,367,133
2025-11-07	EVMNEvommune, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.56M sh	$16.00	+$25M	4,929,633
2025-11-07	EVMNEvommune, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−15.5M sh	—	—	0
2025-11-07	EVMNEvommune, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−5.09M sh	—	—	0
2025-11-07	EVMNEvommune, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−6.59M sh	—	—	0

Recent filings

2

Accepted (ET)
Feb 184
Verduyn-van Weegen Felice Isabel0002094941-26-000002
SEC(opens sec.gov)
Nov 124
Verduyn-van Weegen Felice Isabel0002094941-25-000004
SEC(opens sec.gov)

Companies

2

Address

AGOMAB THERAPEUTICS NV POSTHOFLEI 1/6

ANTWERPEN, 2600